InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Jain Abhinav. Director active across 3 companies, notably Aytu Biopharma, INC. In total, 11 disclosures have been recorded. Activity tracked since 11 August 2023. The latest transaction was disclosed on 15 August 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
JAIN ABHINAV is a declarant linked to Aytu Biopharma, INC, TALPHERA, INC., and Xtant Medical Holdings, Inc., where the listed role is Director. He has 10 filings in total, and the sampled recent filings run from 2023-08-15 to 2026-07-30, with buy and sell amounts of EUR 0 and a modal transaction nature of Attribution.